Daejeon, South Korea

Joo Hong Park

This inventor holds 1 USPTO granted patent. Top assignee: Lg Chemical Ltd.. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joo Hong Park. Retrieved from https://idiyas.com/inventor/joo-hong-park

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Joo Hong Park: Innovator in Human Embryonic Cell Research

Introduction

Joo Hong Park is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of human embryonic cell strains. His work is essential for advancing medical research and therapeutic applications.

Latest Patents

Joo Hong Park holds a patent for a "Human embryonic lung fibroblast diploid cell strain suitable for the." This innovation is crucial for various biomedical applications, showcasing his expertise in cell biology and regenerative medicine.

Career Highlights

He is currently employed at LG Chemical Ltd., where he continues to push the boundaries of scientific research. His role at the company allows him to collaborate with other experts in the field and contribute to groundbreaking projects.

Collaborations

Some of his notable coworkers include Jeong Min Kim and Bock Ryeon Park. Together, they work on innovative projects that aim to enhance the understanding and application of human embryonic cells in medicine.

Conclusion

Joo Hong Park's contributions to biotechnology and his innovative patent highlight his role as a leading inventor in the field. His work at LG Chemical Ltd. and collaborations with fellow researchers further emphasize his commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…